Evidence map›Paper›PMID 24958192›Full record

ArticleNeurobiology of aging2014

Genome-wide association interaction analysis for Alzheimer's disease.

Elena S Gusareva, Minerva M Carrasquillo, Céline Bellenguez, Elise Cuyvers, Samuel Colon, Neill R Graff-Radford, Ronald C Petersen, Dennis W Dickson, Jestinah M Mahachie John, Kyrylo Bessonov and 9 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Neurobiology of aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Quantitative Trait Module-Based Genetic Analysis of Alzheimer's Disease.International journal of molecular sciences · 2019
    Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Ramirez, Alfredo [Added]
5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

Elena S GusarevaSystems and Modeling Unit, Montefiore Institute, University of Liege, Belgium; Bioinformatics and Modeling, GIGA-R, University of Liege, Belgium. Electronic address: egusareva@ulg.ac.be.
Minerva M CarrasquilloDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA.
Céline BellenguezINSERM U744, Lille, France; Department of Public Health and Molecular Epidemiology of Aging Related Diseases, Institut Pasteur de Lille, Lille, France; Universite de Lille Nord de France, Lille, France.
Elise CuyversDepartment of Molecular Genetics, VIB, Antwerp, Belgium; Department of Neurology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Samuel ColonDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic Florida, Jacksonville, FL, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic Florida, Rochester, MN, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA.
Jestinah M Mahachie JohnSystems and Modeling Unit, Montefiore Institute, University of Liege, Belgium; Bioinformatics and Modeling, GIGA-R, University of Liege, Belgium.
Kyrylo BessonovSystems and Modeling Unit, Montefiore Institute, University of Liege, Belgium; Bioinformatics and Modeling, GIGA-R, University of Liege, Belgium.
Christine Van BroeckhovenDepartment of Molecular Genetics, VIB, Antwerp, Belgium; Department of Neurology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
GERAD1 Consortium
Denise HaroldMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK.
Julie WilliamsMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Cardiff, UK.
Philippe AmouyelINSERM U744, Lille, France; Department of Public Health and Molecular Epidemiology of Aging Related Diseases, Institut Pasteur de Lille, Lille, France; Universite de Lille Nord de France, Lille, France.
Kristel SleegersDepartment of Molecular Genetics, VIB, Antwerp, Belgium; Department of Neurology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Nilüfer Ertekin-TanerDepartment of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA; Department of Neurology, Mayo Clinic Florida, Jacksonville, FL, USA.
Jean-Charles LambertINSERM U744, Lille, France; Department of Public Health and Molecular Epidemiology of Aging Related Diseases, Institut Pasteur de Lille, Lille, France; Universite de Lille Nord de France, Lille, France.
Kristel Van SteenSystems and Modeling Unit, Montefiore Institute, University of Liege, Belgium; Bioinformatics and Modeling, GIGA-R, University of Liege, Belgium.
Mayo Clinic in Florida · USUniversity of Liège · BEInserm · FRUniversity of Antwerp · BECardiff University · GBJacksonville College · US

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI Tammie Lee Smith Benzinger · 1985 to 2026
$69.5M
Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI SCHINDLER, SUZANNE ELIZABETH · 2005 to 2025
$49.5M
Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
GENOMIC SEARCH FOR SUSCEPTIBILITY TO ALZHEIMER DISEASER01AG016208 · NIA · WASHINGTON UNIVERSITY · PI GOATE, ALISON M · 1999 to 2010
$5.8M
Gene discovery in PSP by transcriptome, neuropathology and sequence analysisR01NS080820 · NINDS · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2013 to 2017
$1.8M
Genome wide association study of gene expression levels in Alzheimer's diseaseR01AG032990 · NIA · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2009 to 2011
$932k
Medical Research Council G0000934Medical Research Council G0300429Medical Research Council G0902227Medical Research Council G1001799Medical Research Council MR/K013041/1Medical Research Council MR/L010305/1Medical Research Council MR/L501517/1NCATS NIH HHS UL1 TR000135NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P01-AG026276NIA NIH HHS P01-AG03991NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG016574NIA NIH HHS P50AG016574NIA NIH HHS P50-AG05681NIA NIH HHS R01 AG016208NIA NIH HHS R01 AG032990NIA NIH HHS R01 AG032990,NIA NIH HHS R01-AG16208NIA NIH HHS U01 AG006786NIDDK NIH HHS U01 DK062418NINDS NIH HHS R01 NS080820Wellcome TrustWellcome Trust 068545/Z/02Wellcome Trust GR082604MA
6 · The paper itself

Abstract

We propose a minimal protocol for exhaustive genome-wide association interaction analysis that involves screening for epistasis over large-scale genomic data combining strengths of different methods and statistical tools. The different steps of this protocol are illustrated on a real-life data application for Alzheimer's disease (AD) (2259 patients and 6017 controls from France). Particularly, in the exhaustive genome-wide epistasis screening we identified AD-associated interacting SNPs-pair from chromosome 6q11.1 (rs6455128, the KHDRBS2 gene) and 13q12.11 (rs7989332, the CRYL1 gene) (p = 0.006, corrected for multiple testing). A replication analysis in the independent AD cohort from Germany (555 patients and 824 controls) confirmed the discovered epistasis signal (p = 0.036). This signal was also supported by a meta-analysis approach in 5 independent AD cohorts that was applied in the context of epistasis for the first time. Transcriptome analysis revealed negative correlation between expression levels of KHDRBS2 and CRYL1 in both the temporal cortex (β = -0.19, p = 0.0006) and cerebellum (β = -0.23, p < 0.0001) brain regions. This is the first time a replicable epistasis associated with AD was identified using a hypothesis free screening approach.

Indexed as

Alzheimer DiseaseCerebellumCohort StudiesCrystallinsEpistasis, GeneticFemaleGene ExpressionGene Expression ProfilingGenome-Wide Association StudyHumansMaleMeta-Analysis as TopicRNA-Binding ProteinsTemporal LobeCRYL1 protein, humanCrystallinsKHDRBS2 protein, humanRNA-Binding ProteinsAlzheimerComplex trait analysisEpistasisGWAIReplication

Identifiers

PMID24958192
PMCPMC4370231
OpenAlexW2147976902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.